Clinical Trial Update: A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating isatuximab combined with pomalidomide and dexamethasone in multiple myeloma patients who had one prior line including lenalidomide and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Isatuximab (isatuximab)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Hellenic Society of Hematology | Conditions: Multiple Myeloma, Renal Impairment | Phase 2 | Status: UNKNOWN